Expanding the Phenotype of TUFM ‐ Related Combined Oxidative Phosphorylation Deficiency 4
American Journal of Medical Genetics Part A · 2026-08 · 200 (8) · 1884-1889
DOI: 10.1002/ajmg.a.70136 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 22.03.2026. Verfasst von Noémie Villeneuve-Cloutier und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, CHEO, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Cardiomyopathy, Hypertrophic. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Combined oxidative phosphorylation deficiency 4 (COXPD4) is a rare mitochondrial condition caused by biallelic deleterious variants in the nuclear‐encoded gene TUFM . To date, most individuals with COXPD4 have presented with encephalopathy, hypotonia, and abnormal brain imaging. Many of the reported individuals died in infancy. We aim to expand the clinical and biochemical phenotype of COXPD4 by reporting on an adult with this condition. Our proband has a homozygous TUFM c.1025T>G, p.(Val342Gly) variant. He has sensorineural hearing loss, hyperlactatemia with mild illness, and reduced activity in mitochondrial complexes I, III, and IV on endomyocardial biopsy. He presents with hypertrophic cardiomyopathy and chronic kidney failure, which have not previously been reported in this condition. Our findings suggest not all individuals with COXPD4 present with significant neurological involvement and highlight the importance of considering COXPD4 as part of the differential diagnosis of hypertrophic cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, CHEO, Ottawa, Ontario, Canada.
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
- Department of Medicine, Neurology, The Ottawa Hospital, Ottawa, Ontario, Canada.
- Division of Metabolics and Newborn Screening, CHEO, Ottawa, Ontario, Canada.
ORCID-Profile: Jodi Warman-Chardon, Danielle K Bourque
Zitieren
APA
Villeneuve-Cloutier, N., Warman-Chardon, J., & Bourque, D. K. (2026). Expanding the Phenotype of TUFM ‐ Related Combined Oxidative Phosphorylation Deficiency 4. American Journal of Medical Genetics Part A, 200(8), 1884-1889. https://doi.org/10.1002/ajmg.a.70136
Vancouver
Villeneuve-Cloutier N, Warman-Chardon J, Bourque DK. Expanding the Phenotype of TUFM ‐ Related Combined Oxidative Phosphorylation Deficiency 4. American Journal of Medical Genetics Part A. 2026;200(8):1884-1889. doi:10.1002/ajmg.a.70136
BibTeX
@article{VilleneuveCloutier2026,
author = {Villeneuve-Cloutier, Noémie and Warman-Chardon, Jodi and Bourque, Danielle K},
title = {Expanding the Phenotype of TUFM ‐ Related Combined Oxidative Phosphorylation Deficiency 4},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
volume = {200},
number = {8},
pages = {1884--1889},
doi = {10.1002/ajmg.a.70136}
}
EUVIMED